Virginia Kimonis Selected Research

Vision Disorders (Hemeralopia)

1/2021

A p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Virginia Kimonis Research Topics

Disease

21	Muscular Diseases (Myopathy) 03/2024 - 03/2005
18	Frontotemporal Dementia (Semantic Dementia) 03/2024 - 03/2005
16	Osteitis Deformans (Paget's Disease of Bone) 03/2024 - 02/2014
15	Proteostasis Deficiencies 03/2024 - 02/2014
10	Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia 03/2024 - 02/2007
9	Prader-Willi Syndrome (Syndrome, Prader-Willi) 05/2022 - 04/2011
5	Muscle Weakness 03/2024 - 02/2015
5	Fabry Disease (Fabry's Disease) 11/2023 - 03/2021
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023 - 01/2018
4	Glycogen Storage Disease Type II (Pompe's Disease) 03/2024 - 07/2019
4	Muscle Hypotonia (Hypotonia) 01/2022 - 01/2018
4	Craniosynostoses (Craniosynostosis) 04/2014 - 09/2007
3	Disease Progression 03/2024 - 01/2018
3	Hyperphagia (Overeating) 01/2023 - 01/2019
3	Dementia (Dementias) 01/2023 - 10/2015
3	Neoplasms (Cancer) 01/2022 - 12/2020
2	Bone Diseases (Bone Disease) 03/2024 - 01/2023
2	Inborn Genetic Diseases (Disease, Hereditary) 03/2024 - 01/2023
2	Obesity 01/2023 - 09/2022
2	Parkinson Disease (Parkinson's Disease) 10/2022 - 01/2012
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2022
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 10/2015
2	Angelman Syndrome (Syndrome, Angelman) 10/2019 - 08/2010
2	autosomal dominant Inclusion body myopathy 02/2007 - 03/2005
1	Metabolic Bone Diseases (Osteopenia) 03/2024
1	Osteoporosis 03/2024
1	Nonaka type Distal myopathy 12/2023
1	Respiratory Insufficiency (Respiratory Failure) 11/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2023
1	Type 2I Charcot-Marie-Tooth disease 01/2023
1	Neuroblastoma 01/2023
1	Type II Distal Hereditary Motor Neuropathy 01/2023
1	Neuralgia (Stump Neuralgia) 06/2022
1	Parkinsonian Disorders (Parkinsonism) 01/2022
1	Cognitive Dysfunction 01/2022
1	Abdominal Obesity 01/2022
1	Movement Disorders (Movement Disorder) 01/2022
1	Toxic Optic Neuropathy 01/2022
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2022

Drug/Important Bio-Agent (IBA)

21	Valosin Containing ProteinIBA 03/2024 - 03/2005
7	Merozoite Surface Protein 1 (MSA1)IBA 03/2024 - 01/2021
7	EnzymesIBA 03/2024 - 10/2005
7	Growth Hormone (Somatotropin)IBA 05/2022 - 04/2011
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2017
5	UbiquitinIBA 06/2022 - 03/2005
4	GlycogenIBA 03/2024 - 07/2019
4	LipidsIBA 01/2021 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2018
3	AcidsIBA 03/2024 - 07/2019
3	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2022 - 02/2010
2	alpha-Glucosidases (Acid Maltase)IBA 03/2024 - 07/2019
2	agalsidase beta FDA Link 11/2023 - 12/2021
2	GlucosidasesIBA 11/2023 - 01/2022
2	Diazoxide (Hyperstat)FDA Link 01/2023 - 01/2019
2	Oxytocin (Pitocin)FDA LinkGeneric 01/2023 - 05/2017
2	Choline (Choline Chloride)IBA 01/2023 - 01/2019
2	Carrier Proteins (Binding Protein)IBA 01/2023 - 01/2021
2	migalastatIBA 06/2022 - 12/2021
2	CB-5083IBA 01/2022 - 01/2021
2	NucleotidesIBA 01/2022 - 01/2021
2	Retinaldehyde (Retinal)IBA 01/2022 - 01/2017
2	CytokinesIBA 12/2021 - 02/2014
2	Folic Acid (Vitamin M)FDA LinkGeneric 10/2019 - 08/2010
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2019 - 08/2010
2	Betaine (C.B.B.)FDA Link 10/2019 - 08/2010
1	Glycogen Synthase (Synthase I)IBA 03/2024
1	Antisense OligonucleotidesIBA 03/2024
1	Galectin 3 (LGALS3)IBA 04/2023
1	CKD732IBA 01/2023
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2023
1	TabletsIBA 01/2023
1	GhrelinIBA 01/2023
1	setmelanotideIBA 01/2023
1	TubulinIBA 01/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2023
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2023
1	CalciumIBA 01/2023
1	ActininIBA 01/2023
1	Crystallins (Crystallin)IBA 01/2023
1	polyglutamineIBA 01/2023
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2023
1	MyogeninIBA 01/2023
1	alpha-SynucleinIBA 10/2022
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 09/2022
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 09/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2022
1	LeptinIBA 09/2022
1	trkB ReceptorIBA 09/2022
1	Proprotein Convertase 1IBA 09/2022
1	Leptin ReceptorsIBA 09/2022
1	globotriaosylceramide (globotriosylceramide)IBA 06/2022
1	snRNP Core ProteinsIBA 01/2022

Therapy/Procedure

6	Enzyme Replacement Therapy 11/2023 - 12/2020
5	Therapeutics 03/2024 - 01/2021
4	Sutures (Suture) 04/2014 - 09/2007
1	Transcranial Direct Current Stimulation 01/2023
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2022
1	Resistance Training 01/2022
1	Occupational Therapy (Therapy, Occupational) 01/2022